Physician profile
Judith Elson
NPI 1043267537
$1,183.57
in general payments reported to CMS, 2019-2025
12 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $228 · 2023: $120 · 2024: $37.85 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $187.85 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $185.60 | 2019-2020 | |
| Allergan, INC. | $178.89 | 2019 | |
| Kala Pharmaceuticals, INC. | $141.26 | 2019-2020 | |
| Alcon Vision LLC | $119.99 | 2023 | Total30 |
| Coopervision INC. | $117.92 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Shire North American Group INC | $76.45 | 2019 | |
| Eyevance Pharmaceuticals LLC | $50.90 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $45.88 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $32.32 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $23.63 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $22.88 | 2024 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Elson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.